← Leaderboards
Motomu Shimaoka
Immune Disease Institute, Inc.
$5,119,836
Attributed
$5,119,836
Total exposure
4
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.3M · FY2005–10$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
Funding mix
By agency
NIH$5,119,836 · 4
By mechanism
R01$2,531,472 · 2
P01$2,091,887 · 1
RC1$496,477 · 1
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Cells”
- Lawrence Corey · Fred Hutchinson Cancer Center$536,344,731
- Barton F Haynes · Duke University$457,457,619
- David Heimbrook · Leidos Biomedical Research, Inc.$454,789,509
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$299,104,942
- Dennis R. Burton · Scripps Research Institute$278,781,854
- Mary M Horowitz · Medical College Of Wisconsin$237,383,608
Research focus
CellsAffinityIntegrinsMolecular ConformationLeukocytesAntibodiesIn VivoTissuesInflammatoryClinical TrialsLigandsT-LymphocyteInvestigationPlayPathogenesisSmall MoleculePhage DisplayLigand BindingLigand Binding DomainPhysiologicalEfalizumabGenerationsComplexCell Surface
Grant awards (12)
Integrin-targeted siRNA delivery for therapeutic gene silencing in blood cancers$452,691
R01 · FY2010 · CA · contact PI
Targeted siRNA delivery to aberrantly activated leukocytes for treating colitis$496,477
RC1 · FY2009 · DK · contact PI
Integrin LFA-1 antagonists$439,505
R01 · FY2009 · AI · contact PI
Aberrant Activation of Integrins on Leukocytes$383,546
P01 · FY2009 · HL · contact PI
Integrin LFA-1 antagonists$395,554
R01 · FY2008 · AI · contact PI
Aberrant Activation of Integrins on Leukocytes$365,266
P01 · FY2008 · HL · contact PI
Aberrant Activation of Integrins on Leukocytes$456,848
P01 · FY2007 · HL · contact PI
Integrin LFA-1 antagonists$403,214
R01 · FY2007 · AI · contact PI
Aberrant Activation of Integrins on Leukocytes$449,660
P01 · FY2006 · HL · contact PI
Integrin LFA-1 antagonists$415,258
R01 · FY2006 · AI · contact PI
Aberrant Activation of Integrins on Leukocytes$436,567
P01 · FY2005 · HL
Integrin LFA-1 antagonists$425,250
R01 · FY2005 · AI